DoW Rare Cancers Concept Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Posted 17 Jun 2026 · Closes today
In plain terms
The US Defense Health Agency funds novel, groundbreaking research concepts in rare cancers through its FY26 Concept Award programme, which does not require preliminary data. The programme is open to any type of organisation established in the United States, with a total programme budget of 2.52 million US dollars, and the application deadline was 30 September 2026.
A generated summary of the donor's text; the original wording is below.
Summary
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Concept Award (CA) supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. Applications must describe how the new idea will be innovative and present as a novel course of investigation in the field of rare cancers.
Distinctive Features:
Preliminary data are not required.
Due to the blinded nature of the review process, identifying or making references to the Principal Investigator (PI), collaborator(s), or their organization(s) in the proposal Project Narrative, Supporting Documentations, Impact Statement, Justification Statement, and Statement of Work (SOW) is prohibited and will result in administrative rejection of the application.
Excerpt from the donor's page. The full text, annexes and forms are on the original call.
Who can apply
- ngo_cso
- academia_research
- private_company
- government
- individual
- other
Eligibility and conditions
Show the eligibility text from the source
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"